| Autor: |
Burmester GR; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Coates LC; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre, Oxford, UK., Cohen SB; Metroplex Clinical Research Center and Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX, USA., Tanaka Y; First Department of Internal Medicine, University of Occupational and Environmental Health Japan, Kitakyushu, Japan., Vranic I; Pfizer Ltd, Tadworth, UK., Nagy E; Pfizer Ltd, Tadworth, UK., Lazariciu I; Pfizer Inc, New York, NY, USA., Chen AS; Pfizer Inc, Groton, CT, USA., Kwok K; Pfizer Inc, New York, NY, USA., Fallon L; Inflammation and Immunology, Pfizer Canada ULC, 17300 Trans-Canada Hwy, Kirkland, QC, H9J 2M5, Canada., Kinch C; Inflammation and Immunology, Pfizer Canada ULC, 17300 Trans-Canada Hwy, Kirkland, QC, H9J 2M5, Canada. cassandra.kinch@pfizer.com. |
